These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 26308575)
1. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A. Xu BH; Li XX; Yang Y; Zhang MY; Rao HL; Wang HY; Zheng XF Oncotarget; 2015 Aug; 6(25):20813-28. PubMed ID: 26308575 [TBL] [Abstract][Full Text] [Related]
2. Rab1A is an mTORC1 activator and a colorectal oncogene. Thomas JD; Zhang YJ; Wei YH; Cho JH; Morris LE; Wang HY; Zheng XF Cancer Cell; 2014 Nov; 26(5):754-69. PubMed ID: 25446900 [TBL] [Abstract][Full Text] [Related]
3. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice. Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751 [TBL] [Abstract][Full Text] [Related]
4. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression. Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789 [TBL] [Abstract][Full Text] [Related]
5. Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage. Wang X; Liu F; Qin X; Huang T; Huang B; Zhang Y; Jiang B Aging (Albany NY); 2016 Nov; 8(11):2790-2798. PubMed ID: 27902464 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A. Xiong B; Huang J; Liu Y; Zou M; Zhao Z; Gong J; Wu X; Qiu C Cell Oncol (Dordr); 2021 Apr; 44(2):329-343. PubMed ID: 33074477 [TBL] [Abstract][Full Text] [Related]
7. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer. Cheng Z; Shao X; Xu M; Wang J; Kuai X; Zhang L; Wu J; Zhou C; Mao J Oncol Rep; 2019 May; 41(5):2717-2728. PubMed ID: 30896866 [TBL] [Abstract][Full Text] [Related]
8. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735 [TBL] [Abstract][Full Text] [Related]
10. PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer. Fan SJ; Snell C; Turley H; Li JL; McCormick R; Perera SM; Heublein S; Kazi S; Azad A; Wilson C; Harris AL; Goberdhan DC Oncogene; 2016 Jun; 35(23):3004-15. PubMed ID: 26434594 [TBL] [Abstract][Full Text] [Related]
11. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways. Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024 [TBL] [Abstract][Full Text] [Related]
12. Expression analysis and implication of Rab1A in gastrointestinal relevant tumor. Xu M; Shao X; Kuai X; Zhang L; Zhou C; Cheng Z Sci Rep; 2019 Sep; 9(1):13384. PubMed ID: 31527621 [TBL] [Abstract][Full Text] [Related]
13. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma. Dong P; Wang X; Liu L; Tang W; Ma L; Zeng W; Sun S; Zhang L; Zhang N; Shen X; Janssen HLA; Dong L; Zhang S; Chen S J Hepatol; 2020 Dec; 73(6):1446-1459. PubMed ID: 32610114 [TBL] [Abstract][Full Text] [Related]
14. CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo. Xie Z; Wang J; Liu M; Chen D; Qiu C; Sun K PLoS One; 2017; 12(3):e0173252. PubMed ID: 28334043 [TBL] [Abstract][Full Text] [Related]
15. Requirement for lysosomal localization of mTOR for its activation differs between leucine and other amino acids. Averous J; Lambert-Langlais S; Carraro V; Gourbeyre O; Parry L; B'Chir W; Muranishi Y; Jousse C; Bruhat A; Maurin AC; Proud CG; Fafournoux P Cell Signal; 2014 Sep; 26(9):1918-27. PubMed ID: 24793303 [TBL] [Abstract][Full Text] [Related]
16. HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT. Noh JH; Bae HJ; Eun JW; Shen Q; Park SJ; Kim HS; Nam B; Shin WC; Lee EK; Lee K; Jang JJ; Park WS; Lee JY; Nam SW Cancer Res; 2014 Mar; 74(6):1728-38. PubMed ID: 24448241 [TBL] [Abstract][Full Text] [Related]
17. MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation. Dong Z; Qi R; Guo X; Zhao X; Li Y; Zeng Z; Bai W; Chang X; Hao L; Chen Y; Lou M; Li Z; Lu Y Biochem Biophys Res Commun; 2017 Jan; 483(1):630-637. PubMed ID: 27998765 [TBL] [Abstract][Full Text] [Related]
18. Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Park YY; Sohn BH; Johnson RL; Kang MH; Kim SB; Shim JJ; Mangala LS; Kim JH; Yoo JE; Rodriguez-Aguayo C; Pradeep S; Hwang JE; Jang HJ; Lee HS; Rupaimoole R; Lopez-Berestein G; Jeong W; Park IS; Park YN; Sood AK; Mills GB; Lee JS Hepatology; 2016 Jan; 63(1):159-72. PubMed ID: 26389641 [TBL] [Abstract][Full Text] [Related]
19. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway. Li Z; Li Y; Jia Y; Ding B; Yu J Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637 [TBL] [Abstract][Full Text] [Related]
20. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis. Liu P; Ge M; Hu J; Li X; Che L; Sun K; Cheng L; Huang Y; Pilo MG; Cigliano A; Pes GM; Pascale RM; Brozzetti S; Vidili G; Porcu A; Cossu A; Palmieri G; Sini MC; Ribback S; Dombrowski F; Tao J; Calvisi DF; Chen L; Chen X Hepatology; 2017 Jul; 66(1):167-181. PubMed ID: 28370287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]